| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 256 | 679 | 7.880 | 905 | 422 | 861 | 0 | 0 | 0 |
| Total Expenses - EUR | 133.978 | 41.606 | 49 | 10.142 | 1.283 | 46 | 23 | 18 | 0 | 217 |
| Gross Profit/Loss - EUR | -133.978 | -41.350 | 630 | -2.262 | -378 | 375 | 838 | -18 | 0 | -217 |
| Net Profit/Loss - EUR | -133.978 | -41.350 | 630 | -2.479 | -378 | 375 | 838 | -18 | 0 | -217 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmanord Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.058 | 32.465 | 31.916 | 21.286 | 20.873 | 20.478 | 20.024 | 20.086 | 20.025 | 19.913 |
| Current Assets | 142.699 | 38.942 | 38.913 | 39.318 | 39.518 | 39.144 | 39.114 | 39.217 | 39.098 | 38.662 |
| Inventories | 258 | 245 | 241 | 236 | 232 | 227 | 222 | 223 | 222 | 221 |
| Receivables | 141.492 | 36.580 | 35.961 | 35.301 | 34.618 | 33.961 | 33.208 | 33.311 | 33.210 | 33.025 |
| Cash | 948 | 2.117 | 2.711 | 3.781 | 4.669 | 4.955 | 5.683 | 5.683 | 5.666 | 5.417 |
| Shareholders Funds | -1.451.608 | -1.478.154 | -1.452.512 | -1.428.334 | -1.400.982 | -1.374.047 | -1.342.738 | -1.346.922 | -1.342.838 | -1.335.550 |
| Social Capital | 449.944 | 445.355 | 437.819 | 429.784 | 421.461 | 413.471 | 404.302 | 405.556 | 404.326 | 402.067 |
| Debts | 1.632.365 | 1.549.562 | 1.523.340 | 1.488.938 | 1.461.373 | 1.433.669 | 1.401.876 | 1.406.225 | 1.401.961 | 1.394.125 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Farmanord Srl